Michael Forer
InvestorPartner at Rosetta Capital Ltd.
About
Michael Forer co-founded Rosetta in 2001 and has over 20 years of experience in the life science sector as an entrepreneur, advisor, and investor, beginning at Rothschild Asset Management. As a partner at Auven Therapeutics, he led the Spirogen investment (later sold to AstraZeneca) and the spin-out of ADC Therapeutics. He holds a BA in economics, a diploma in international business, and an LLB from the University of British Columbia, and articled at the predecessor firm of Norton Rose Canada.
Invests in
Biotech
Investments
Led
Spirogen
Board seats
AditechKDev InvestmentsResonant MedicalRose Pharma
Investor
ADC Therapeutics
Per the firm's website.
Colleagues at Rosetta Capital Ltd.
Frequently asked questions
- Who is Michael Forer?
- Michael Forer co-founded Rosetta in 2001 and has over 20 years of experience in the life science sector as an entrepreneur, advisor, and investor, beginning at Rothschild Asset Management. As a partner at Auven Therapeutics, he led the Spirogen investment (later sold to AstraZeneca) and the spin-out of ADC Therapeutics. He holds a BA in economics, a diploma in international business, and an LLB from the University of British Columbia, and articled at the predecessor firm of Norton Rose Canada.
- Where does Michael Forer work?
- Michael Forer is Partner at Rosetta Capital Ltd..
- What does Michael Forer invest in?
- Michael Forer invests in Biotech.
- What boards does Michael Forer sit on?
- Michael Forer holds tracked board seats at Aditech, KDev Investments, Resonant Medical, Rose Pharma.
- What companies has Michael Forer invested in?
- Investments tracked here include Spirogen, ADC Therapeutics.
- Does Michael Forer lead rounds?
- Yes — Michael Forer has led 1 tracked investment.